Work

Assessing the clinical development of zerlasiran, a small-interfering RNA for elevated lipoprotein(a)

Year: 2025

Type: article

Source: Expert Opinion on Investigational Drugs

DOI: 10.1080/13543784.2025.2598458

Authors: Xuan L. Tang, Amanda J. Hooper, John R. Burnett

Institutions: Royal Perth Hospital, Fiona Stanley Hospital, Pathwest Laboratory Medicine, The University of Western Australia

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416817026

FWCI:

Cites: 33

Cited by:

Related to: